Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. (Q42452538)
Jump to navigation
Jump to search
scientific article published on November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. |
scientific article published on November 2003 |
Statements
Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand (English)
Keiji Wakabayashi
Naoko Niho
Yutaka Shoji
Yoshito Takeuchi
Satoshi Matsubara
1 November 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference